Grant: Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Direct Payment
$150,000.00
Reconstruction of Regulatory Networks Mediating Persistent Inflammation in HIV Infection
FY 2009-10
Summary
Substantial progress has been made in the treatment and prevention of HIV/AIDS, especially in resource-rich regions where antiretroviral drugs are readily available. The continuous development of new antiretroviral drugs, together with the current use of combination antiretroviral therapy (cART), has resulted in substantial declines in AIDS-associated morbidity and mortality, reducing the frequency of opportunistic infections and prolonging survival. Despite the success of cART, there is great variability among individual therapeutic responses. Poor therapeutic responses are frequently associated with increased mortality as well as non-AIDS associated morbidities, including cardiovascular disease, liver disease, and cancer. Understanding the cellular mechanisms that regulate immune reconstitution is important for optimizing current treatment strategies. HIV causes early severe damage to the gut, which leads to activation of the immune system and chronic inflammation, even in patients on treatment. These findings have focused attention on the pathological processes of immune activation in HIV-infected individuals and its potential role in treatment failure. The goal of this proposal is to understand the dysfunctional immune responses that drive chronic inflammation and limit therapeutic responses in HIV-infected individuals on current treatments. The study will identify molecular signatures and develop computational models that predict therapeutic responses to antiretroviral therapy. To accomplish these goals, we will use advanced technologies to analyze complex immune regulatory networks. These innovative studies involve the assembly and analysis of large datasets using state-of-the-art statistical and computational methods. This information may provide insights that will enable the development of immune-based or other new therapeutic strategies that can be used in conjunction with current treatment regimens to improve therapeutic outcomes.
Department
Program
Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
204532
Name
Cassol Edana
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Reconstruction of Regulatory Networks Mediating Persistent Inflammation in HIV Infection
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Fellowship - PA: Biomedical / Clinical HIV/AIDS Research
Keyworddelim
Aids; Antiretroviral Therapy; Hiv; Immune Activation; Innate Immunity; Pathogenesis; Systems Biology
Abstract
Substantial progress has been made in the treatment and prevention of HIV/AIDS, especially in resource-rich regions where antiretroviral drugs are readily available. The continuous development of new antiretroviral drugs, together with the current use of combination antiretroviral therapy (cART), has resulted in substantial declines in AIDS-associated morbidity and mortality, reducing the frequency of opportunistic infections and prolonging survival. Despite the success of cART, there is great variability among individual therapeutic responses. Poor therapeutic responses are frequently associated with increased mortality as well as non-AIDS associated morbidities, including cardiovascular disease, liver disease, and cancer. Understanding the cellular mechanisms that regulate immune reconstitution is important for optimizing current treatment strategies. HIV causes early severe damage to the gut, which leads to activation of the immune system and chronic inflammation, even in patients on treatment. These findings have focused attention on the pathological processes of immune activation in HIV-infected individuals and its potential role in treatment failure. The goal of this proposal is to understand the dysfunctional immune responses that drive chronic inflammation and limit therapeutic responses in HIV-infected individuals on current treatments. The study will identify molecular signatures and develop computational models that predict therapeutic responses to antiretroviral therapy. To accomplish these goals, we will use advanced technologies to analyze complex immune regulatory networks. These innovative studies involve the assembly and analysis of large datasets using state-of-the-art statistical and computational methods. This information may provide insights that will enable the development of immune-based or other new therapeutic strategies that can be used in conjunction with current treatment regimens to improve therapeutic outcomes.
Competitiondate
201002
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cassol, Edana
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~